INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

NVSNOVARTIS AG

CIK 0001114448

EDGAR filingsOpen in network
Disclosed transactions1
Buys / sells0 / 1
Max Insider Score24
Connections12with evidence

NVS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
Kevin HernRSelf
NVSNOVARTIS AG
Sale
SELL$15K – $50KAug 27, 2026Sep 25, 2026
traded Aug 27, 2026
+29dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    NOVARTIS CORPORATION POLITICAL ACTION COMMITTEEFEC Form 1 connected organization: NOVARTIS CORPORATION (curated map) · Nov 4, 2026
  • ← Disclosed trade inevidence
    Kevin HernSale disclosed 2026-09-25 · Sep 25, 2026
  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q2 2026 second quarter · Medicare/Medicaid, Trade, Budget/appropriations, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    FORBES-TATELDA Q1 2026 first quarter · Taxation, Health issues, Medicare/Medicaid, Trade, Budget/appropriations, Copyright/patent · Aug 26, 2026
  • ← Lobbied forevidence
    MONUMENT ADVOCACYLDA Q2 2026 second quarter · Health issues, Trade, Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    BROWNSTEIN HYATT FARBER SCHRECK, LLPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Trade · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK HEALTH STRATEGIES, INC.LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    DLA PIPER LLP (US)LDA Q1 2026 first quarter · Copyright/patent, Taxation, Trade, Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERSLDA Q2 2026 second quarter · Trade, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026

    • Lobbying

    $5.34M reported · de-duplicated
    2026 Q2 $1.41M in-house2026 Q1 $3.93M in-house
    • CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS$50K2026 Q1 · posted Aug 26, 2026 · Trade, Health issues
    • TARPLIN, DOWNS & YOUNG, LLC$60K2026 Q1 · posted Aug 26, 2026 · Budget/appropriations, Health issues, Medicare/Medicaid, Trade
    • FORBES-TATE$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Trade, Budget/appropriations, Copyright/patent, Taxation
    • MONUMENT ADVOCACY$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Trade, Taxation
    • TIBER CREEK HEALTH STRATEGIES, INC.$60K2026 Q1 · posted Aug 26, 2026 ·
    • FORBES-TATE$50K2026 Q1 · posted Aug 26, 2026 · Taxation, Health issues, Medicare/Medicaid, Trade, Budget/appropriations, Copyright/patent
    • MONUMENT ADVOCACY$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Trade, Taxation
    • BGR GOVERNMENT AFFAIRS$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • In-house report$3.93M2026 Q1 · posted Aug 26, 2026 · Labor, Budget/appropriations, Copyright/patent, Health issues, Medicare/Medicaid, Taxation, Trade
    • BROWNSTEIN HYATT FARBER SCHRECK, LLP$90K2026 Q1 · posted Aug 26, 2026 · Health issues
    • TARPLIN, DOWNS & YOUNG, LLC$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Trade, Budget/appropriations, Health issues
    • DLA PIPER LLP (US)$60K2026 Q2 · posted Aug 26, 2026 · Copyright/patent, Taxation, Trade, Health issues, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Donald G. DavisD$10KNOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
    • Brett GuthrieR$10KNOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
    • John JoyceR$10KNOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
    • Scott H. PetersD$9,000NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
    • Richard HudsonR$8,500NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Brittany PettersenD$8,000NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Kevin MullinD$7,000NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Martin HeinrichD$6,000NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Gabe AmoD$6,000NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Rudy Yakym IIIR$6,000NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Lori TrahanD$5,500NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE
  • Katherine M. ClarkD$5,500NOVARTIS CORPORATION POLITICAL ACTION COMMITTEE